Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Details
State: Public
Version: Final published version
License: Not specified
Serval ID
serval:BIB_957BAED3FD8F
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus.
Journal
Annals of oncology
Working group(s)
Panel members
Contributor(s)
Addeo A., Albiges L., Ascierto P.A., Banerjee S., Barlesi F., Caldas C., Cardoso F., Cervantes A., Chaberny I.F., Cherny N.I., Choueiri T.K., Chua MLK, Criscitiello C., Curigliano G., de Azambuja E., De Ruysscher D., de Vries E., Dent R., Douillard J.Y., D'Ugo D., Dziadziuszko R., Faivre-Finn C., Felip E., Garassino M., Garrido P., Girard N., Glynne-Jones R., Golfinopoulos V., Haanen J., Hamilton E., Jänne P.A., Jordan K., Kanesvaran R., Kim S.B., Liebert U.G., Lordick F., Machiels J.P., Michielin O., Mok TSK, Morgan G., Obermannova R., Park K., Passaro A., Pentheroudakis G., Peters S., Reck M., Salazar Soler R., Scotté F., Senan S., Sessa C., Smyth E., Soo R., Soria J.C., Spicer J., Strasser F., Tabernero J., Tan DSW, Trapani D., Van Cutsem E., van Halteren H., van Schil P.E., Veronesi G., Yang J.
ISSN
1569-8041 (Electronic)
ISSN-L
0923-7534
Publication state
Published
Issued date
10/2020
Peer-reviewed
Oui
Volume
31
Number
10
Pages
1320-1335
Language
english
Notes
Publication types: Practice Guideline
Publication Status: ppublish
Publication Status: ppublish
Abstract
We established an international consortium to review and discuss relevant clinical evidence in order to develop expert consensus statements related to cancer management during the severe acute respiratory syndrome coronavirus 2-related disease (COVID-19) pandemic. The steering committee prepared 10 working packages addressing significant clinical questions from diagnosis to surgery. During a virtual consensus meeting of 62 global experts and one patient advocate, led by the European Society for Medical Oncology, statements were discussed, amended and voted upon. When consensus could not be reached, the panel revised statements until a consensus was reached. Overall, the expert panel agreed on 28 consensus statements that can be used to overcome many of the clinical and technical areas of uncertainty ranging from diagnosis to therapeutic planning and treatment during the COVID-19 pandemic.
Keywords
Betacoronavirus, Consensus, Coronavirus Infections/epidemiology, Coronavirus Infections/immunology, Coronavirus Infections/therapy, Disease Management, Europe/epidemiology, Granulocyte Colony-Stimulating Factor/pharmacology, Granulocyte Colony-Stimulating Factor/therapeutic use, Humans, Medical Oncology/methods, Medical Oncology/standards, Neoplasms/epidemiology, Neoplasms/immunology, Neoplasms/therapy, Pandemics/prevention & control, Pneumonia, Viral/epidemiology, Pneumonia, Viral/immunology, Pneumonia, Viral/therapy, Real-Time Polymerase Chain Reaction/methods, Real-Time Polymerase Chain Reaction/standards, Societies, Medical/standards, T-Lymphocytes, Cytotoxic/drug effects, T-Lymphocytes, Cytotoxic/immunology, Telemedicine/methods, Telemedicine/standards
Pubmed
Web of science
Open Access
Yes
Create date
13/08/2020 7:32
Last modification date
21/11/2022 8:21
Usage data
